BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21078867)

  • 1. On the mechanism of CFTR inhibition by a thiazolidinone derivative.
    Kopeikin Z; Sohma Y; Li M; Hwang TC
    J Gen Physiol; 2010 Dec; 136(6):659-71. PubMed ID: 21078867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFTR gating I: Characterization of the ATP-dependent gating of a phosphorylation-independent CFTR channel (DeltaR-CFTR).
    Bompadre SG; Ai T; Cho JH; Wang X; Sohma Y; Li M; Hwang TC
    J Gen Physiol; 2005 Apr; 125(4):361-75. PubMed ID: 15767295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CFTR gating II: Effects of nucleotide binding on the stability of open states.
    Bompadre SG; Cho JH; Wang X; Zou X; Sohma Y; Li M; Hwang TC
    J Gen Physiol; 2005 Apr; 125(4):377-94. PubMed ID: 15767296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State-dependent modulation of CFTR gating by pyrophosphate.
    Tsai MF; Shimizu H; Sohma Y; Li M; Hwang TC
    J Gen Physiol; 2009 Apr; 133(4):405-19. PubMed ID: 19332621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects.
    Bompadre SG; Sohma Y; Li M; Hwang TC
    J Gen Physiol; 2007 Apr; 129(4):285-98. PubMed ID: 17353351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzopyrimido-pyrrolo-oxazine-dione (R)-BPO-27 Inhibits CFTR Chloride Channel Gating by Competition with ATP.
    Kim Y; Anderson MO; Park J; Lee MG; Namkung W; Verkman AS
    Mol Pharmacol; 2015 Oct; 88(4):689-96. PubMed ID: 26174774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gating of cystic fibrosis transmembrane conductance regulator chloride channels by adenosine triphosphate hydrolysis. Quantitative analysis of a cyclic gating scheme.
    Zeltwanger S; Wang F; Wang GT; Gillis KD; Hwang TC
    J Gen Physiol; 1999 Apr; 113(4):541-54. PubMed ID: 10102935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the gating behaviour of human and murine cystic fibrosis transmembrane conductance regulator Cl- channels expressed in mammalian cells.
    Lansdell KA; Delaney SJ; Lunn DP; Thomson SA; Sheppard DN; Wainwright BJ
    J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):379-92. PubMed ID: 9508803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions of genistein on cystic fibrosis transmembrane conductance regulator channel gating. Evidence for two binding sites with opposite effects.
    Wang F; Zeltwanger S; Yang IC; Nairn AC; Hwang TC
    J Gen Physiol; 1998 Mar; 111(3):477-90. PubMed ID: 9482713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel by thyroid hormones involves multiple mechanisms.
    Cai Z; Li H; Chen JH; Sheppard DN
    Am J Physiol Cell Physiol; 2013 Oct; 305(8):C817-28. PubMed ID: 23784545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two mechanisms of genistein inhibition of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in murine cell line.
    Lansdell KA; Cai Z; Kidd JF; Sheppard DN
    J Physiol; 2000 Apr; 524 Pt 2(Pt 2):317-30. PubMed ID: 10766914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two rare variants that affect the same amino acid in CFTR have distinct responses to ivacaftor.
    Li H; Rodrat M; Al-Salmani MK; Veselu DF; Han ST; Raraigh KS; Cutting GR; Sheppard DN
    J Physiol; 2024 Jan; 602(2):333-354. PubMed ID: 38186087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamics of CFTR channel gating: a spreading conformational change initiates an irreversible gating cycle.
    Csanády L; Nairn AC; Gadsby DC
    J Gen Physiol; 2006 Nov; 128(5):523-33. PubMed ID: 17043148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for CFTR inhibition by CFTR
    Young PG; Levring J; Fiedorczuk K; Blanchard SC; Chen J
    Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2316675121. PubMed ID: 38422021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator.
    Yu YC; Sohma Y; Hwang TC
    J Physiol; 2016 Jun; 594(12):3227-44. PubMed ID: 26846474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting CFTR inhibition: a comparative study of CFTRinh -172 and GlyH-101 inhibitors.
    Melis N; Tauc M; Cougnon M; Bendahhou S; Giuliano S; Rubera I; Duranton C
    Br J Pharmacol; 2014 Aug; 171(15):3716-27. PubMed ID: 24758416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable ATP binding mediated by a partial NBD dimer of the CFTR chloride channel.
    Tsai MF; Li M; Hwang TC
    J Gen Physiol; 2010 May; 135(5):399-414. PubMed ID: 20421370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker.
    Taddei A; Folli C; Zegarra-Moran O; Fanen P; Verkman AS; Galietta LJ
    FEBS Lett; 2004 Jan; 558(1-3):52-6. PubMed ID: 14759515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics.
    Zhou Z; Wang X; Liu HY; Zou X; Li M; Hwang TC
    J Gen Physiol; 2006 Oct; 128(4):413-22. PubMed ID: 16966475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of phenylalanine 508 causes attenuated phosphorylation-dependent activation of CFTR chloride channels.
    Wang F; Zeltwanger S; Hu S; Hwang TC
    J Physiol; 2000 May; 524 Pt 3(Pt 3):637-48. PubMed ID: 10790148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.